Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00378105 · BASELINE

Baseline characteristics

Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma · Source last updated 2026-02-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      31
    2. group Id
      BG001
      value
      35
    3. group Id
      BG002
      value
      66
    units
    Participants
groups
  1. id
    BG000
    title
    Phase 1 Population
  2. id
    BG001
    title
    Phase 2 Population
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          36
          upper Limit
          73
          value
          57
        2. group Id
          BG001
          lower Limit
          22
          upper Limit
          86
          value
          59
        3. group Id
          BG002
          lower Limit
          22
          upper Limit
          86
          value
          58
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
        2. group Id
          BG001
          value
          16
        3. group Id
          BG002
          value
          30
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          17
        2. group Id
          BG001
          value
          19
        3. group Id
          BG002
          value
          36
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
The numbers excluded 2 patients who went off study prior to start of therapy (phase I part).
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      31
    2. group Id
      BG001
      value
      35
    3. group Id
      BG002
      value
      66
    units
    Participants
groups
  1. id
    BG000
    title
    Phase 1 Population
  2. id
    BG001
    title
    Phase 2 Population
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          36
          upper Limit
          73
          value
          57
        2. group Id
          BG001
          lower Limit
          22
          upper Limit
          86
          value
          59
        3. group Id
          BG002
          lower Limit
          22
          upper Limit
          86
          value
          58
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
        2. group Id
          BG001
          value
          16
        3. group Id
          BG002
          value
          30
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          17
        2. group Id
          BG001
          value
          19
        3. group Id
          BG002
          value
          36
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
The numbers excluded 2 patients who went off study prior to start of therapy (phase I part).

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice